Jessie Lyn Kautzman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 401 S Alabama St Ste 6a, Butte, MT 59701 Phone: 406-563-7239 Fax: 406-782-2890 |
Patrick J Mcgree, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 S Clark St, Butte, MT 59701 Phone: 406-782-2239 Fax: 406-782-4634 |
Dr. Serena Zephyr Brewer, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 |
Lori Jane Lagerquist, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 S Crystal St, Suite 200, Butte, MT 59701 Phone: 406-496-3600 Fax: 406-496-3653 |
Dr. Michael E Lefever, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3251 Nettie St, Butte, MT 59701 Phone: 406-560-6679 Fax: 406-723-1288 |
Dr. Warren M Swager, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 Continental Dr, Butte, MT 59701 Phone: 406-496-5400 Fax: 406-496-5437 |
Dr. Shawna Marie Yates, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 Fax: 406-496-6035 |
Donna Smith, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-496-6000 Fax: 406-496-6035 |
Dr. Kathren Elaine Mcgree, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 S Clark St, Butte, MT 59701 Phone: 406-782-2239 |
Dr. Jordan Hugart Greer, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 401 S Washington St, Butte, MT 59701 Phone: 406-299-2944 |
Dr. Mikhail Joutovsky, D.O Family Medicine - Addiction Medicine Medicare: Medicare Enrolled Practice Location: 1341 Harrison Ave Ste 15, Butte, MT 59701 Phone: 406-299-2944 Fax: 406-299-2944 |
Kellee Rose Glaus, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3636 Harrison Ave, Butte, MT 59701 Phone: 406-496-3600 Fax: 406-206-1971 |
Dr. Carey Downey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 445 Centennial Ave, Butte, MT 59701 Phone: 406-723-4075 Fax: 406-723-3059 |
Lisa K Sessions, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 401 S Alabama St Ste 6a, Butte, MT 59701 Phone: 406-782-2329 Fax: 406-782-0289 |
Richard Kozakiewicz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 418 W Monroe Ave, Chester, MT 59522 Phone: 406-759-5194 |
Judy E Borland, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 4th St. Nw, Choteau, MT 59422 Phone: 406-466-5763 Fax: 406-466-2159 |
Kristen M Lamping, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Faith Ln, Clancy, MT 59634 Phone: 907-360-7814 |
Derek James Williams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 204 Winslow Road, Clancy, MT 59634 Phone: 406-461-0875 |
Dr. Reginald Joseph Goodwin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 191 Mcclellan Creek Rd, Clancy, MT 59634 Phone: 406-443-5455 |
Jose F Ortiz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6230 Main, Colstrip, MT 59323 Phone: 406-748-3600 Fax: 406-748-3606 |
News Archive
When researchers examined information on pairs of kidneys from the same donor in which 1 kidney was used but the other was discarded, the kidneys that were used tended to perform well even though they were similar in quality to their partner kidneys that were not used.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Gabapentin Tablets USP, 600 mg and 800 mg, the generic version of Pfizer's Neurontin Tablets for the treatment of postherpetic neuralgia, a complication of shingles.
In this Lancet opinion piece, Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, examines a number of social, political, and financial issues at play ahead of the November 6 U.S. presidential election and their implications for domestic and global health programs.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has successfully completed enrollment and treatment of the last patient in its Phase I clinical trial of CUDC-101, Curis' first-in-class HDAC, EGFR and HER2 inhibitor.
› Verified 1 days ago